References
- Xu H, Wang L, Yan K, Zhu H, Pan H, Yang H, et al. Nuciferine inhibited the differentiation and lipid accumulation of 3T3-L1 preadipocytes by regulating the expression of lipogenic genes and adipokines. Front Pharmacol 2021;12:632236.
- Zhang C, Deng J, Liu D, Tuo X, Yu Y, Yang H, et al. Nuciferine inhibits proinflammatory cytokines via the PPARs in LPS-induced RAW264.7 cells. Molecules 2018;23:2723.
- Kim SM, Park EJ, Lee HJ. Nuciferine attenuates lipopolysaccharide-stimulated inflammatory responses by inhibiting p38 MAPK/ATF2 signaling pathways. Inflammopharmacology 2022;30:2373-2383. https://doi.org/10.1007/s10787-022-01075-y
- Tilaoui M, Ait Mouse H, Zyad A. Update and new insights on future cancer drug candidates from plant-based alkaloids. Front Pharmacol 2021;12:719694.
- Bishayee A, Patel PA, Sharma P, Thoutireddy S, Das N. Lotus (Nelumbo nucifera Gaertn.) and its bioactive phytocompounds: a tribute to cancer prevention and intervention. Cancers (Basel) 2022;14:529.
- Chen J, Ye Y, Ran M, Li Q, Ruan Z, Jin N. Inhibition of tyrosinase by mercury chloride: spectroscopic and docking studies. Front Pharmacol 2020;11:81.
- Zolghadri S, Bahrami A, Hassan Khan MT, Munoz-Munoz J, Garcia-Molina F, Garcia-Canovas F, et al. A comprehensive review on tyrosinase inhibitors. J Enzyme Inhib Med Chem 2019;34:279-309. https://doi.org/10.1080/14756366.2018.1545767
- Ullah S, Park C, Ikram M, Kang D, Lee S, Yang J, et al. Tyrosinase inhibition and anti-melanin generation effect of cinnamamide analogues. Bioorg Chem 2019;87:43-55. https://doi.org/10.1016/j.bioorg.2019.03.001
- Omasits U, Ahrens CH, Muller S, Wollscheid B. Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics 2014;30:884-886. https://doi.org/10.1093/bioinformatics/btt607
- Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993;234:779-815. https://doi.org/10.1006/jmbi.1993.1626
- National Center for Biotechnology Information. PubChem Compound Summary for CID 3840, Kojic acid. Bethesda: National Center for Biotechnology Information, 2023. Accessed 2023 Apr 26. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Kojic-acid.
- National Center for Biotechnology Information. PubChem Compound Summary for CID 54670067, Ascorbic Acid. Bethesda: National Center for Biotechnology Information, 2023. Accessed 2023 Apr 26. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Ascorbic-Acid.
- National Center for Biotechnology Information. PubChem Compound Summary for CID 71543007, Isobutylamido thiazolyl resorcinol. Bethesda: National Center for Biotechnology Information, 2023. Accessed 2023 Apr 26. Available from: https://pub-chem.ncbi.nlm.nih.gov/compound/Isobutylamido-thiazolyl-re-sorcinol.
- Roulier B, Rush I, Lazinski LM, Peres B, Olleik H, Royal G, et al. Resorcinol-based hemiindigoid derivatives as human tyrosinase inhibitors and melanogenesis suppressors in human melanoma cells. Eur J Med Chem 2023;246:114972.
- Nazir Y, Rafique H, Roshan S, Shamas S, Ashraf Z, Rafiq M, et al. Molecular docking, synthesis, and tyrosinase inhibition activity of acetophenone amide: potential inhibitor of melanogenesis. Biomed Res Int 2022;2022:1040693.
- Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model 2021;61:3891-3898. https://doi.org/10.1021/acs.jcim.1c00203
- Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455-461. https://doi.org/10.1002/jcc.21334
- Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics 2016;54:5.6.1-5.6.37. https://doi.org/10.1002/cpbi.3
- Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000;29:291-325. https://doi.org/10.1146/annurev.biophys.29.1.291
- Lai X, Wichers HJ, Soler-Lopez M, Dijkstra BW. Structure and function of human tyrosinase and tyrosinase-related proteins. Chemistry 2018;24:47-55. https://doi.org/10.1002/chem.201704410
- Xu X, Sun CR, Dai XJ, Hu RL, Pan YJ, Yang ZF. LC/MS guided isolation of alkaloids from lotus leaves by pH-zone-refining counter-current chromatography. Molecules 2011;16:2551-2560. https://doi.org/10.3390/molecules16032551
- Pasam K, Mallojala V, Gunda SK, Bandi S. Homology modelling and molecular docking studies of interleukin 10 proteins from different species. Int J Pharm Invest 2019;9:154-157. https://doi.org/10.5530/ijpi.2019.4.29
- Mann T, Gerwat W, Batzer J, Eggers K, Scherner C, Wenck H, et al. Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase. J Invest Dermatol 2018;138:1601-1608. https://doi.org/10.1016/j.jid.2018.01.019
- Kanteev M, Goldfeder M, Fishman A. Structure-function correlations in tyrosinases. Protein Sci 2015;24:1360-1369. https://doi.org/10.1002/pro.2734
- Zou C, Huang W, Zhao G, Wan X, Hu X, Jin Y, et al. Determination of the bridging ligand in the active site of tyrosinase. Molecules 2017;22:1836.
- Kim DH, Kim SJ, Ullah S, Yun HY, Chun P, Moon HR. Design, synthesis, and antimelanogenic effects of (2-substituted phenyl1,3-dithiolan-4-yl)methanol derivatives. Drug Des Devel Ther 2017;11:827-836. https://doi.org/10.2147/DDDT.S131538
- Ishioka W, Oonuki S, Iwadate T, Nihei KI. Resorcinol alkyl glucosides as potent tyrosinase inhibitors. Bioorg Med Chem Lett 2019;29:313-316. https://doi.org/10.1016/j.bmcl.2018.11.029
- Senol FS, Khan MT, Orhan G, Gurkas E, Orhan IE, Oztekin NS, et al. In silico approach to inhibition of tyrosinase by ascorbic acid using molecular docking simulations. Curr Top Med Chem 2014;14:1469-1472. https://doi.org/10.2174/1568026614666140610121253
- Mann T, Scherner C, Rohm KH, Kolbe L. Structure-activity relationships of thiazolyl resorcinols, potent and selective inhibitors of human tyrosinase. Int J Mol Sci 2018;19:690.
- Li J, Feng L, Liu L, Wang F, Ouyang L, Zhang L, et al. Recent advances in the design and discovery of synthetic tyrosinase inhibitors. Eur J Med Chem 2021;224:113744.